NCT02401191View on ClinicalTrials.gov

A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Rhinitis Allergic

Interventions

DRUG

FEX60/PE10

Pharmaceutical form:tablet Route of administration: oral

Trial Locations (1)

Unknown

Sanofi Administrative Office, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY